Clinical Trial Update: Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Ivonescimab (AK112/SMT112) in combination with stereotactic body radiation therapy and chemotherapy for pancreatic cancer is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Pancreatic Cancer | Phase 2 | Status: RECRUITING